ArticleCellular & molecular immunology2022

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.

Stéphane Pillet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.